Your browser doesn't support javascript.
Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis.
Purkayastha, Pujon; Mckechnie, Charlie; Kalkur, Pallavi; Scully, Marie.
  • Purkayastha P; Acute Medicine, Southend Hospital, Westcliff-on-Sea, UK dr.purkayastha@doctors.org.uk.
  • Mckechnie C; Acute Medicine, Southend Hospital, Westcliff-on-Sea, UK.
  • Kalkur P; Acute Medicine, Southend Hospital, Westcliff-on-Sea, UK.
  • Scully M; Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
BMJ Case Rep ; 14(9)2021 Sep 23.
Article in English | MEDLINE | ID: covidwho-1438072
ABSTRACT
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a relatively novel term which describes patients who have developed a low platelet count and prothrombotic tendencies secondary to receiving a vaccine. The concept has been derived from the well-established phenomenon of heparin-induced thrombocytopenia, and several cases of VITT have now been reported in patients who have received the AstraZeneca (ChAdOx1 nCov-19) vaccine. Unfortunately, some of these patients have gone on to develop intracranial venous sinus thrombosis. We present a case of VITT-associated sinus thrombosis secondary to the AstraZeneca (ChAdOx1 nCov-19) vaccine, which was complicated by a large intracerebral haemorrhage.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sinus Thrombosis, Intracranial / Vaccines / COVID-19 Type of study: Case report Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bcr-2021-245092

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Sinus Thrombosis, Intracranial / Vaccines / COVID-19 Type of study: Case report Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bcr-2021-245092